Clinical trial
Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot…
NCT00316537 · CoMentis, Industry · Terminated
Key facts
| NCT number | NCT00316537 |
|---|---|
| Title | Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers |
| Official title | A Multicenter, Randomized Study of the Safety and Preliminary Efficacy of Low-Dose Nicotine Gel (ATG002) in Patients With Plantar Diabetic Foot Ulcers |
| Lead sponsor | CoMentis, Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Foot Ulcers |
| Intervention type | Drug |
| Interventions | ATG002 (study drug) |
| Enrollment | 48 |
| Start date | Oct 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Apr 21, 2006 |
| Last update posted | Aug 9, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: